Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

pharmacogenetics

  • Open Access
    Integrated Pharmacogenetic Signature for the Prediction of Prostatic Neoplasms in Men With Metabolic Disorders
    MARIA PAGONI, VASILEIOS L. ZOGOPOULOS, STAVROS KONTOGIANNIS, ANNIA TSOLAKOU, VASSILIOS ZOUMPOURLIS, GEORGE TH. TSANGARIS, ELEFTHERIOS FOKAEFS, IOANNIS MICHALOPOULOS, ARISTIDIS M. TSATSAKIS and NIKOLAOS DRAKOULIS
    Cancer Genomics & Proteomics March 2025, 22 (2) 285-305; DOI: https://doi.org/10.21873/cgp.20502
  • Open Access
    Pharmacogenetics of Toxicities Related to Endocrine Treatment in Breast Cancer: A Systematic Review and Meta-analysis
    KINAN MOKBEL, MICHAEL WEEDON, VICTORIA MOYE and LEIGH JACKSON
    Cancer Genomics & Proteomics September 2024, 21 (5) 421-438; DOI: https://doi.org/10.21873/cgp.20461
  • Open Access
    Dihydropyrimidine Dehydrogenase Gene (DPYD) Polymorphism among Caucasian and non-Caucasian Patients with 5-FU- and Capecitabine-related Toxicity Using Full Sequencing of DPYD
    MUHAMMAD WASIF SAIF
    Cancer Genomics & Proteomics March 2013, 10 (2) 89-92;
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire